Trial Profile
Phase 2b study of RBX7455
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2018
Price :
$35
*
At a glance
- Drugs RBX 7455 (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 16 Jan 2018 New trial record
- 09 Jan 2018 According to a Rebiotix media release, this study is expected to start in 2018.